Docetu (Docetaxel) 20 mg/ml, 80 mg/ml, 160 mg/8 ml
Product Description
Onko Ilac Sanayi ve Ticaret A.S.
-
TR -
2015On CPHI since
-
3Certificates
-
500 - 999Employees
Company types
Primary activities
Categories
Onko Ilac Sanayi ve Ticaret A.S.
-
TR
-
2015On CPHI since
-
3Certificates
-
500 - 999Employees
Company types
Primary activities
More Products from Onko Ilac Sanayi ve Ticaret A.S. (35)
-
Product Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml
Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml is used along with cancer chemotherapy to treat bone damage caused by multiple myeloma or by cancer that began in another part of the body but has spread to the bones. Please contact us for more information. -
Product Bortezomib Onko (Bortezomib), 3.5 mg, Powder for solution for Injection-Vial
Bortezomib Onko (Bortezomib), 3.5 mg, is in Powder for solution for Injection-Vial form. Bortezomib is an antineoplastic agent which is used to treat people with multiple myeloma and mantle cell lymphoma. Contact us for more information. -
Product Azatu (Azacitidine), 100 mg, Powder for Injection Suspension-Vial
Azacitidine,100 mg, Powder for Injection Suspension- Vial is used to treat acute myelogenous leukemia, chronic myelogenous leukemia (CML), myelodysplastic syndrome. Contact us for more information. -
Product Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml
Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml is used along with cancer chemotherapy to treat bone damage caused by multiple myeloma or by cancer that began in another part of the body but has spread to the bones. Please contact us for more information.
... -
Product Kopaq (Iohexol), Concentrated Solution for Injection - Vial, 300 mgI/ml (50 ml), 300 mgI/ml (100 ml), 350 mgl/ml (50 ml), 350 mgl/ml (100 ml), 350 mgl/ml (200 ml)
Kopaq (Iohexol), Concentrated Solution for Injection - Vial, 300 mgI/ml (50 ml), 300 mgI/ml (100 ml), 350 mgl/ml (50 ml), 350 mgl/ml (100 ml), 350 mgl/ml (200 ml) is a iodinated, nonionic, low osmolar contrast agent.The product is used in arthrography, endoscopic retrograde pancreatography (ERP), endoscopi... -
Product Misintu (Mitomycin), 20 mg, Powder for Solution for Injection/Infusion
Misintu (Mitomycin), 20 mg, Powder for Solution for Injection/Infusion is used to treat bladder cancer, breast cancer, head and neck cancer, stomach and pancreatic cancer, prostate cancer and cervical cancer. Contact us for more information. -
Product Epiritu (Epirubicine HCL) 10 mg/5 ml, 200 mg/100 ml, 50 mg/25 ml
Epiritu is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as an "anthracyline antitumor antibiotic. Epiritu is used to treat breast cancer. It is used as adjuvant therapy in women who have had surgery and have lymph node involvement.May be... -
Product Azacitidine Injection 100mg/vial (Azacitidine)
This medication is used to treat a group of blood/bone marrow disorders (myelodysplastic syndromes-MDS) in which the bone marrow does not produce enough healthy blood cells -
Product Bortezomib Injection 3.5 mg vial (Bortezomib)
It is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma -
Product Doxtu (Doxorubicine HCL) 10 mg/5 ml, 50 mg/25 ml
Doxtu is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. Doxorubicin is classified as an “anthracycline antibiotic.” Doxtu is administered via an intravenous (IV) injection through a central line or a peripheral venous line, and the drug is given over several minutes. Contact us fo... -
Product Gemtu (Gemcitabine HCL) 1000mg/10ml, 2000mg/20ml, 200mg/2ml
Gemtu (gemcitabine for injection) is a nucleoside metabolic inhibitor that exhibits antitumor activity. Gemcitabine HCl is 2´-deoxy-2´,2´-difluorocytidine monohydrochloride (β-isomer). Gemtu in combination with carboplatin is indicated for the treatment of patients with advanced ovarian cancer&nb... -
Product Paclitu (Paclitaxel) 100mg/16.7 ml, 300 mg/50 ml, 150 mg/25 ml, 30 mg/5 ml
Paclitu injection is used to treat advanced cancer of the ovaries, breast, non-small cell lung cancer, and Kaposi sarcoma. Kaposi sarcoma is a cancer of the skin and mucous membranes that is commonly found in patients with acquired immunodeficiency syndrome (AIDS). Paclitu belongs to the group of medi...
Onko Ilac Sanayi ve Ticaret A.S. resources (2)
-
News Bortezomib Injection 3.5 mg vial DCP application
Onko Koçsel is proud that Bortezomib Injection 3.5 mg vial DCP application has been successfully accepted by EMA member countries on March, 2021. Onko Koçsel is open for collaboration within and outside EU countries.
-
Video Onko Kocsel Factory video
Onko Kocsel Factory video
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance